Correlation Between BioSig Technologies, and Heart Test

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioSig Technologies, and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioSig Technologies, and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioSig Technologies, Common and Heart Test Laboratories, you can compare the effects of market volatilities on BioSig Technologies, and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioSig Technologies, with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioSig Technologies, and Heart Test.

Diversification Opportunities for BioSig Technologies, and Heart Test

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BioSig and Heart is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding BioSig Technologies, Common and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and BioSig Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioSig Technologies, Common are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of BioSig Technologies, i.e., BioSig Technologies, and Heart Test go up and down completely randomly.

Pair Corralation between BioSig Technologies, and Heart Test

Given the investment horizon of 90 days BioSig Technologies, Common is expected to generate 2.96 times more return on investment than Heart Test. However, BioSig Technologies, is 2.96 times more volatile than Heart Test Laboratories. It trades about 0.25 of its potential returns per unit of risk. Heart Test Laboratories is currently generating about -0.1 per unit of risk. If you would invest  111.00  in BioSig Technologies, Common on August 31, 2024 and sell it today you would earn a total of  68.00  from holding BioSig Technologies, Common or generate 61.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BioSig Technologies, Common  vs.  Heart Test Laboratories

 Performance 
       Timeline  
BioSig Technologies, 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in BioSig Technologies, Common are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, BioSig Technologies, displayed solid returns over the last few months and may actually be approaching a breakup point.
Heart Test Laboratories 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Heart Test may actually be approaching a critical reversion point that can send shares even higher in December 2024.

BioSig Technologies, and Heart Test Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioSig Technologies, and Heart Test

The main advantage of trading using opposite BioSig Technologies, and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioSig Technologies, position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.
The idea behind BioSig Technologies, Common and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Share Portfolio
Track or share privately all of your investments from the convenience of any device